De C. Oliveira
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical Response to Poly(ADP-ribose) Polymerase Inhibitor in Metastatic Breast Cancer With a Germline Reduced-Penetrance BRCA2 Pathogenic Variant: A Molecular Tumor Board Discussion.
Journal: JCO precision oncology
Published: April 03, 2026
Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520).
Journal: JCO oncology practice
Published: March 06, 2026
Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 study.
Journal: Breast (Edinburgh, Scotland)
Published: May 04, 2025
Understanding and overcoming CDK4/6 inhibitor resistance in HR+/HER2- metastatic breast cancer: clinical and molecular perspectives.
Journal: Therapeutic advances in medical oncology
Published: March 06, 2025
Real-World Treatment Patterns and Outcomes in Hormone Receptor Positive HER2 Negative Early-Stage Breast Cancer in a Private Community Oncology Practice of Brazil.
Journal: Clinical breast cancer
Published: February 23, 2025
A portrait of germline pathogenic variants in high and moderate penetrance breast cancer genes in Brazil.
Journal: Frontiers in oncology
Published: September 12, 2024
Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil.
Journal: Cancer treatment and research communications
Published: December 06, 2022
Vitamin D and colorectal cancer - A practical review of the literature.
Journal: Cancer treatment and research communications
Published: May 16, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026